Company Overview - Zhenghai Biological Technology Co., Ltd. specializes in the research, production, and sales of bio-regenerative materials, with key products including oral repair membranes, absorbable dura mater patches, skin repair membranes, and bone repair materials [1] - The company has over 20 years of development history and has participated in national programs such as the "863 Program" and the National Torch Program, recognized as a national "specialized, refined, and innovative" small giant enterprise and a high-tech enterprise [1] Financial Performance - For the first half of 2025, the company reported revenue of 188 million yuan, a year-on-year decrease of 5.14%, and a net profit of 46.49 million yuan, down 45.97% year-on-year, with a gross profit margin of 83.92% [1] - The current stock price is 21.62 yuan, with a rolling price-to-earnings (PE) ratio of 40.92 times, and a total market capitalization of 3.892 billion yuan [1] Industry Comparison - The average PE ratio for the medical device industry is 53.93 times, with a median of 37.81 times, placing Zhenghai Biological at the 81st position in the industry ranking [1] - The company is held by five institutions, including three funds, with a total holding of approximately 19.97 million shares valued at 409 million yuan [1][2]
正海生物收盘下跌1.77%,滚动市盈率40.92倍,总市值38.92亿元